Targeted Degradation of the Oncogenic Phosphatase SHP2

Vemulapalli, Vidyasiri; Donovan, Katherine A.; Seegar, Tom C.M.; Rogers, Julia M.; Bae, Munhyung; Lumpkin, Ryan J.; Cao, Ruili; Henke, Matthew T.; Ray, Soumya S.; Fischer, Eric S.; Cuny, Gregory D.; Blacklow, Stephen C.

doi:10.1021/acs.biochem.1c00377

Targeted Degradation of the Oncogenic Phosphatase SHP2

Journal Article · 01 August 2021 · Biochemistry-US

DOI:https://doi.org/10.1021/acs.biochem.1c00377· OSTI ID:1829853

Vemulapalli, Vidyasiri; Donovan, Katherine A.; Seegar, Tom C.M.; Rogers, Julia M.; Bae, Munhyung; Lumpkin, Ryan J.; Cao, Ruili; Henke, Matthew T.; Ray, Soumya S.; Fischer, Eric S.; Cuny, Gregory D.; Blacklow, Stephen C.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH); UNIVERSITY

OSTI ID:: 1829853

Journal Information:: Biochemistry-US, Vol. 60, Issue (34)

Country of Publication:: United States

Language:: ENGLISH

References (34)

Activating Mutations of the Noonan Syndrome-Associated *SHP2/PTPN11* Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S. Cancer Research, Vol. 64, Issue 24 https://doi.org/10.1158/0008-5472.CAN-04-1923	journal	December 2004
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra Nature Genetics, Vol. 34, Issue 2 https://doi.org/10.1038/ng1156	journal	April 2003
Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase: Domain Opening in SHP2 Phosphatase Darian, Eva; Guvench, Olgun; Yu, Bing Proteins: Structure, Function, and Bioinformatics, Vol. 79, Issue 5 https://doi.org/10.1002/prot.22984	journal	March 2011
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man Nature, Vol. 535, Issue 7610 https://doi.org/10.1038/nature18621	journal	June 2016
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine Okazaki, T.; Maeda, A.; Nishimura, H. Proceedings of the National Academy of Sciences, Vol. 98, Issue 24 https://doi.org/10.1073/pnas.231486598	journal	November 2001
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade Zhao, Mingxia; Guo, Wenjie; Wu, Yuanyuan Acta Pharmaceutica Sinica B, Vol. 9, Issue 2 https://doi.org/10.1016/j.apsb.2018.08.009	journal	March 2019
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling Liu, Chen; Lu, Hengyu; Wang, Hongyun Clinical Cancer Research, Vol. 27, Issue 1 https://doi.org/10.1158/1078-0432.CCR-20-2718	journal	October 2020
Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2 LaRochelle, Jonathan R.; Fodor, Michelle; Xu, Xiang Biochemistry, Vol. 55, Issue 15 https://doi.org/10.1021/acs.biochem.5b01287	journal	April 2016
Off-target inhibition by active site-targeting SHP2 inhibitors Tsutsumi, Ryouhei; Ran, Hao; Neel, Benjamin G. FEBS Open Bio, Vol. 8, Issue 9 https://doi.org/10.1002/2211-5463.12493	journal	August 2018
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application Yuan, Xinrui; Bu, Hong; Zhou, Jinpei Journal of Medicinal Chemistry, Vol. 63, Issue 20 https://doi.org/10.1021/acs.jmedchem.0c00249	journal	May 2020
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P. Journal of Medicinal Chemistry, Vol. 59, Issue 17 https://doi.org/10.1021/acs.jmedchem.6b00680	journal	July 2016
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers Nichols, Robert J.; Haderk, Franziska; Stahlhut, Carlos Nature Cell Biology, Vol. 20, Issue 9 https://doi.org/10.1038/s41556-018-0169-1	journal	August 2018
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer LaMarche, Matthew J.; Acker, Michael; Argintaru, Andreea Journal of Medicinal Chemistry, Vol. 63, Issue 22 https://doi.org/10.1021/acs.jmedchem.0c01170	journal	September 2020
A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial Ou, S. I.; Koczywas, M.; Ulahannan, S. Journal of Thoracic Oncology, Vol. 15, Issue 2 https://doi.org/10.1016/j.jtho.2019.12.041	journal	February 2020
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR Lu, Hengyu; Liu, Chen; Huynh, Hung Oncotarget, Vol. 11, Issue 3 https://doi.org/10.18632/oncotarget.27435	journal	January 2020
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome Donovan, Katherine A.; An, Jian; Nowak, Radosław P. eLife, Vol. 7 https://doi.org/10.7554/eLife.38430	journal	August 2018
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Towards automated crystallographic structure refinement with phenix.refine Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel Acta Crystallographica Section D Biological Crystallography, Vol. 68, Issue 4 https://doi.org/10.1107/S0907444912001308	journal	March 2012
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Acta Crystallographica Section D Biological Crystallography, Vol. 65, Issue 10 https://doi.org/10.1107/S0907444909029436	journal	September 2009
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
Collaboration gets the most out of software Morin, Andrew; Eisenbraun, Ben; Key, Jason eLife, Vol. 2 https://doi.org/10.7554/eLife.01456	journal	September 2013
Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival Lin, Kai-Min; Lin, Sue-Jane; Lin, Juin-Han Journal of Virology, Vol. 94, Issue 4 https://doi.org/10.1128/JVI.01837-19	journal	January 2020
Phthalimide conjugation as a strategy for in vivo target protein degradation Winter, G. E.; Buckley, D. L.; Paulk, J. Science, Vol. 348, Issue 6241 https://doi.org/10.1126/science.aab1433	journal	May 2015
Targeted degradation of the enhancer lysine acetyltransferases CBP and p300 Vannam, Raghu; Sayilgan, Jan; Ojeda, Samuel Cell Chemical Biology, Vol. 28, Issue 4 https://doi.org/10.1016/j.chembiol.2020.12.004	journal	April 2021
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy Wang, Liguo; Shao, Xuejing; Zhong, Tianbai Nature Chemical Biology, Vol. 17, Issue 5 https://doi.org/10.1038/s41589-021-00742-5	journal	March 2021
Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide Zhang, Fangqing; Wu, Zhenwei; Chen, Pan Bioorganic & Medicinal Chemistry, Vol. 28, Issue 1 https://doi.org/10.1016/j.bmc.2019.115228	journal	January 2020
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition LaRochelle, Jonathan R.; Fodor, Michelle; Vemulapalli, Vidyasiri Nature Communications, Vol. 9, Issue 1 https://doi.org/10.1038/s41467-018-06823-9	journal	October 2018
Degradation of target protein in living cells by small-molecule proteolysis inducer Zhang, Dong; Baek, Sun-Hee; Ho, Abby Bioorganic & Medicinal Chemistry Letters, Vol. 14, Issue 3 https://doi.org/10.1016/j.bmcl.2003.11.042	journal	February 2004
Delineating the role of cooperativity in the design of potent PROTACs for BTK Zorba, Adelajda; Nguyen, Chuong; Xu, Yingrong Proceedings of the National Academy of Sciences, Vol. 115, Issue 31 https://doi.org/10.1073/pnas.1803662115	journal	July 2018
Development of selective small molecule MDM2 degraders based on nutlin Wang, Bo; Wu, Suzhen; Liu, Jin European Journal of Medicinal Chemistry, Vol. 176 https://doi.org/10.1016/j.ejmech.2019.05.046	journal	August 2019
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression Li, Yangbing; Yang, Jiuling; Aguilar, Angelo Journal of Medicinal Chemistry, Vol. 62, Issue 2 https://doi.org/10.1021/acs.jmedchem.8b00909	journal	December 2018
Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein Wang, Mingliang; Lu, Jianfeng; Wang, Mi Journal of Medicinal Chemistry, Vol. 63, Issue 14 https://doi.org/10.1021/acs.jmedchem.0c00471	journal	May 2020
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders Yang, Xiangbo; Wang, Zhijia; Pei, Yuan European Journal of Medicinal Chemistry, Vol. 218 https://doi.org/10.1016/j.ejmech.2021.113341	journal	June 2021

Similar Records

Targeted Degradation of the Oncogenic Phosphatase SHP2

Journal Article · 2021 · Biochemistry-US · OSTI ID:1834933

Vemulapalli, Vidyasiri; Donovan, Katherine A.; Seegar, Tom C.M.; +9 more

Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2

Journal Article · 2017 · Bioorganic and Medicinal Chemistry · OSTI ID:1414467

LaRochelle, Jonathan R.; Fodor, Michelle; Ellegast, Jana M.; +9 more

Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)

Journal Article · 2010 · J. Med. Chem. · OSTI ID:1002587

Zhang, Xian; He, Yantao; Liu, Sijiu; +10 more

Targeted Degradation of the Oncogenic Phosphatase SHP2

Citation Formats

References (34)

Similar Records

Related Subjects